Novelion Therapeutics Inc - Strategy, SWOT and Corporate Finance Report

Novelion Therapeutics Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company

Key Highlights

Novelion Therapeutics Inc (Novelion), formerly QLT Inc, is a biopharmaceutical company that focuses on the development and commercialization of products and solutions for the treatment of people living with rare diseases. The company has two marketed products - Lomitapide, a small molecule microsomal triglyceride transfer protein inhibitor which is marketed under the brand name JUXTAPID in the US for treating homozygous familial hypercholesterolemia (HoFH) in adult patients; and Metreleptin, a recombinant analog of human leptin which is marketed under the brand name MYALEPT in the US for treating congenital or acquired generalized lipodystrophy (GL) patients. The company operates along with its subsidiaries across North America, South America, Europe and Asia. Novelion is headquartered in Vancouver, British Columbia, Canada.

Scope

  • Detailed information on Novelion Therapeutics Inc required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting Novelion Therapeutics Inc in the form of a SWOT analysis
  • An in-depth view of the business model of Novelion Therapeutics Inc including a breakdown and examination of key business segments
  • News about Novelion Therapeutics Inc, such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

  • Gain understanding of Novelion Therapeutics Inc and the factors that influence its strategies.
  • Track strategic initiatives of the company and latest corporate news and actions.
  • Assess Novelion Therapeutics Inc as a prospective partner, vendor or supplier.
  • Support sales activities by understanding your customers' businesses better.
  • Stay up to date on Novelion Therapeutics Incs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

The Medicines Company

Sanofi

RegenxBio Inc

Regeneron Pharmaceuticals Inc

Gemphire Therapeutics Inc

Eli Lilly and Co

Amgen Inc

Alnylam Pharmaceuticals Inc

Akcea Therapeutics Inc

The Medicines Company

Sanofi

RegenxBio Inc

Regeneron Pharmaceuticals Inc

Gemphire Therapeutics Inc

Eli Lilly and Co

Amgen Inc

Alnylam Pharmaceuticals Inc

Akcea Therapeutics Inc

Table of Contents

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Novelion Therapeutics Inc - Key Facts

Novelion ...

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Novelion Therapeutics Inc - Key Facts

Novelion Therapeutics Inc - Key Employees

Novelion Therapeutics Inc - Key Employee Biographies

Novelion Therapeutics Inc - Major Products and Services

Novelion Therapeutics Inc - History

Novelion Therapeutics Inc - Company Statement

Novelion Therapeutics Inc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

Novelion Therapeutics Inc - Business Description

Product Category: Lomitapide

Overview

Performance

Product Category: Metreleptin

Overview

Performance

Geographical Segment: Brazil

Performance

Geographical Segment: Japan

Performance

Geographical Segment: Other Foreign countries

Performance

Geographical Segment: The US

Performance

Novelion Therapeutics Inc - SWOT Analysis

SWOT Analysis - Overview

Novelion Therapeutics Inc - Strengths

Novelion Therapeutics Inc - Weaknesses

Novelion Therapeutics Inc - Opportunities

Novelion Therapeutics Inc - Threats

Novelion Therapeutics Inc - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Novelion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Novelion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Novelion Therapeutics Inc, Recent Deals Summary

Section 5 – Company’s Recent Developments

Jun 24, 2019: Novelion Therapeutics responds to Whitefort Capital Petition

May 07, 2019: Novelion Therapeutics reports first quarter 2019 financial results

Mar 14, 2019: Novelion Therapeutics reports fourth quarter and full year 2018 financial results

Nov 20, 2018: Novelion Therapeutics announces leadership change

Nov 09, 2018: Novelion Therapeutics reports third quarter 2018 financial results

Nov 08, 2018: Novelion Therapeutics subsidiary enters into term Loan Agreement and Novelion provides business update

Aug 23, 2018: Novelion Therapeutics announces next phase of operational improvements

Aug 07, 2018: Novelion Therapeutics Reports Second Quarter 2018 Financial Results

Jul 03, 2018: Novelion Therapeutics Names Mark Corrigan As Executive Chair Of The Board Of Directors

May 10, 2018: Novelion Therapeutics Reports First Quarter 2018 Financial Results

Section 6 – Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer

List of Tables

List of Tables

Novelion Therapeutics Inc, Key Facts

Novelion Therapeutics Inc, Key Employees

Novelion Therapeutics Inc, Key Employee Biographies

Novelion Therapeutics Inc, Major Products and ...

List of Tables

Novelion Therapeutics Inc, Key Facts

Novelion Therapeutics Inc, Key Employees

Novelion Therapeutics Inc, Key Employee Biographies

Novelion Therapeutics Inc, Major Products and Services

Novelion Therapeutics Inc, History

Novelion Therapeutics Inc, Other Locations

Novelion Therapeutics Inc, Subsidiaries

Novelion Therapeutics Inc, Key Competitors

Novelion Therapeutics Inc, Ratios based on current share price

Novelion Therapeutics Inc, Annual Ratios

Novelion Therapeutics Inc, Annual Ratios (Cont...1)

Novelion Therapeutics Inc, Interim Ratios

Novelion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Novelion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Novelion Therapeutics Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Novelion Therapeutics Inc, Performance Chart (2014 - 2018)

Novelion Therapeutics Inc, Ratio Charts

Novelion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, ...

List of Figures

Novelion Therapeutics Inc, Performance Chart (2014 - 2018)

Novelion Therapeutics Inc, Ratio Charts

Novelion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Novelion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports